Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
fludeoxyglucose f-18 (2015)
radiolabeled albumin technetium Tc-99m albumin colloid kit (Microlite) (1976)
rubidium chloride rb-82 (2016)
sodium fluoride (18F) (2015)
sodium iodide i-131 (iodotope) (2003)
technetium-99m exametazine (Ceretec) (2017)
technetium tc-99m medronate kit (1978)
technetium tc-99m pentetate kit (renotec) (1976)
technetium tc-99m sestamibi (Cardiolite) (2009)
Key: Jubilant DraxImage Inc. (2) Acquired (2)
2-hydroxyoleic acid (3 trials)
iobenguane sulfate i-131 (2 trials)
jbi-802 (1 trial)
temozolomide (temodar) (2 trials)
Neuroblastoma (Phase 2)
Neuroectodermal Tumors (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 2)
Trials (6 total)
Trial APIs (4 total)
